Topics: Chemical industry

  • Uppsala Health Summit publishes pre-conference report

    For the upcoming Uppsala Health Summit on antibiotic resistance, 2–3 June, a report has now been published focusing on some of the most pressing issues and challenges. The aim of the meeting is to move the discussion forward, from the ‘what’ to the ‘who’ and ‘how’.

  • Supermaterial gives rejected drugs a new chance

    More than 80 percent of all drug candidates in the pharma R&D suffer from poor solubility and are therefore rejected early in the drug discovery process. Now Uppsala University researchers show that the new material Upsalite®, has great potential for development of new formulations of these rejected drugs.

Enter your email address to follow Uppsala University

When you choose to create a user account and follow a newsroom your personal data will be used by us and the owner of the newsroom, for you to receive news and updates according to your subscription settings.

To learn more about this, please read our Privacy Policy, which applies to our use of your personal data, and our Privacy Policy for Contacts, which applies to the use of your personal data by the owner of the newsroom you follow.

Please note that our Terms of Use apply to all use of our services.

You can withdraw your consent at any time by unsubscribing or deleting your account.
Check your inbox

Email sent to __email__. Click the link there to follow Uppsala University.

Okay